As of 2024-12-11, the Intrinsic Value of Origin Therapeutics Holdings Inc (ORIG.CN) is
-8.00 CAD. This ORIG.CN valuation is based on the model Peter Lynch Fair Value.
With the current market price of 0.28 CAD, the upside of Origin Therapeutics Holdings Inc is
-3,010.08%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
-8.00 CAD
Intrinsic Value
ORIG.CN Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| Fair Value |
-8.00 - -8.00 |
-8.00 |
-3,010.08% |
| P/E |
0.28 - 0.28 |
0.28 |
2.0% |
| DDM - Stable |
(1.39) - (2.44) |
(1.91) |
-796.4% |
| DDM - Multi |
0.00 - 0.00 |
0.00 |
-100.0% |
ORIG.CN Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
1.42 |
| Beta |
3.55 |
| Outstanding shares (mil) |
5.16 |
| Enterprise Value (mil) |
-1.14 |
| Market risk premium |
5.10% |
| Cost of Equity |
28.45% |
| Cost of Debt |
5.00% |
| WACC |
16.07% |